Weight-Loss drug semaglutide tested for Long-Term appetite control
NCT ID NCT05548647
First seen Oct 31, 2025 · Last updated Apr 29, 2026 · Updated 19 times
Summary
This study looked at how the weight-loss medication semaglutide affects appetite, eating behavior, and food preferences over 72 weeks. 120 adults with obesity or overweight plus related health issues took either semaglutide or a placebo, along with diet and exercise counseling. The goal was to see if the drug helps reduce calorie intake and improve eating habits long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania Center for Weight and Eating Disorders
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.